This closely integrated research proposal is a broad-based effort to analyze fundamental aspects of the biology of parathyroid hormone. A four-fold research effort is proposed: Project I, Evolution of the PTH/PTHrP Receptor and Its Ligands, will determine the structures of PTH, PTHrP, and the PTH/PTHrP receptor in non-mammalian species. The characterization of these structures will provide crucial data for understanding structure-function relationships. The non-mammalian systems will also provide novel model systems for clarifying the functions of these signalling molecules; for example, the roles of PTHrP and PTHrP receptors in early Xenopus development will be studied. Project II, Structural Requirements for Interaction of PTH With Its Receptor, will analyze the functional correlates of the structure of the PTH molecule. Site-directed mutagenesis and chemical synthesis of PTH fragments and analogs will be used as complementary strategies for designing probes for use in these functional studies. Systematic mutagenesis of the cloned PTH/PTHrP receptor cDNA will make possible a detailed analysis of the contacts between PTH and its receptor and the mechanisms whereby binding of ligand on one side of the plasma membrane leads to a conformational change on the cytoplasmic surface. Project III, PTH/PTHrP Receptors: Structure, Signalling, and Regulation, will focus on the way the PTH/PTHrP receptor controls intracellular signalling. A systematic search for and analysis of alternative forms of the PTH/PTHrP receptor will define the relevant signalling molecules. Extensive mutagenesis will be performed to clarify which portions of the receptor activate G proteins; the molecular nature of these G proteins will be clarified. The structural determinants of receptor desensitization and down-regulation will be determined. Project IV, Second Messengers and Regulation of Cellular Function by PTH, will analyze the mechanisms whereby PTH modulates specific cellular activities. An attempt will be made to determine which second messenger pathways control a variety of biologic activities, such as cell proliferation and ion transport. These studies will exploit PTH analogs with novel signalling properties, mutant PTH receptors with altered signalling properties, and mutant cell lines with specific blocks in second messenger pathways, in order to understand the regulation of distal effects of PTH. These studies will provide a firm base for an understanding of diseases of the parathyroid gland and lay the groundwork for potential therapeutic agents for metabolic bone disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Program Projects (P01)
Project #
3P01DK011794-30S1
Application #
2834862
Study Section
Diabetes, Endocrinology and Metabolic Diseases B Subcommittee (DDK)
Program Officer
Margolis, Ronald N
Project Start
1979-01-01
Project End
1998-11-30
Budget Start
1998-08-01
Budget End
1998-11-30
Support Year
30
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02199
Christov, Marta; Clark, Abbe R; Corbin, Braden et al. (2018) Inducible podocyte-specific deletion of CTCF drives progressive kidney disease and bone abnormalities. JCI Insight 3:
Dedic, Christopher; Hung, Tin Shing; Shipley, Alan M et al. (2018) Calcium fluxes at the bone/plasma interface: Acute effects of parathyroid hormone (PTH) and targeted deletion of PTH/PTH-related peptide (PTHrP) receptor in the osteocytes. Bone 116:135-143
Mizuhashi, Koji; Ono, Wanida; Matsushita, Yuki et al. (2018) Resting zone of the growth plate houses a unique class of skeletal stem cells. Nature 563:254-258
Hanna, Patrick; Grybek, Virginie; Perez de Nanclares, Guiomar et al. (2018) Genetic and Epigenetic Defects at the GNAS Locus Lead to Distinct Patterns of Skeletal Growth but Similar Early-Onset Obesity. J Bone Miner Res 33:1480-1488
Wein, Marc N; Foretz, Marc; Fisher, David E et al. (2018) Salt-Inducible Kinases: Physiology, Regulation by cAMP, and Therapeutic Potential. Trends Endocrinol Metab 29:723-735
Bastepe, Murat (2018) GNAS mutations and heterotopic ossification. Bone 109:80-85
Kim, Sang Wan; Lu, Yanhui; Williams, Elizabeth A et al. (2017) Sclerostin Antibody Administration Converts Bone Lining Cells Into Active Osteoblasts. J Bone Miner Res 32:892-901
Roszko, Kelly L; Bi, Ruiye; Gorvin, Caroline M et al. (2017) Knockin mouse with mutant G?11 mimics human inherited hypocalcemia and is rescued by pharmacologic inhibitors. JCI Insight 2:e91079
Grigelioniene, Giedre; Nevalainen, Pasi I; Reyes, Monica et al. (2017) A Large Inversion Involving GNAS Exon A/B and All Exons Encoding Gs? Is Associated With Autosomal Dominant Pseudohypoparathyroidism Type Ib (PHP1B). J Bone Miner Res 32:776-783
Balani, Deepak H; Ono, Noriaki; Kronenberg, Henry M (2017) Parathyroid hormone regulates fates of murine osteoblast precursors in vivo. J Clin Invest 127:3327-3338

Showing the most recent 10 out of 215 publications